CPT code 0254U: Embryo genetics, 24 chromosomes, per embryo2026 Medicare lab fee · Clinical Laboratory Fee Schedule

This per-embryo genomic sequencing assessment evaluates 24 chromosomes and reports a mitochondrial DNA score for euploid embryos in preimplantation reproductive testing.

CMS CLFS 2026 Q4Effective Oct 1, 2026Same amount nationwide

Medicare pays $759.05 for 0254U under the 2026 Clinical Laboratory Fee Schedule: one national amount, the same in every state and setting.

Medicare lab fee · CLFS 2026 Q4

National CLFS amount

$759.05

In effect since Jan 1, 2026. The same amount in every state, payment locality and setting.

Geographic adjustment
None
Office vs facility
Same
Since 2023
Unchanged
CMS updates
Quarterly

Medicare pays the lesser of the lab’s charge and this amount. Patients usually owe no Part B deductible or coinsurance for covered clinical lab tests.

On this page 7 sections
  1. Medicare lab fee
  2. What 0254U covers
  3. How it’s paid
  4. Amount history
  5. Similar tests
  6. Billing questions
  7. Sources

What 0254U covers

This reproductive medicine test uses genomic sequencing of embryonic DNA to assess 24 chromosomes for aneuploidy. It also reports a mitochondrial DNA score for embryos found to be euploid. Reported findings include euploidy, monosomy, trisomy, partial deletions or duplications, mosaicism, and segmental aneuploidy. The assessment supports embryo evaluation in preimplantation reproductive care, with results used by the reproductive medicine team.

Report one unit for each embryo tested. Medicare pays 0254U through the CLFS at one national amount across states and localities, without geographic or office/facility adjustment. The 2026 national CLFS amount is $759.05, unchanged since 2023. Medicare pays this code only through the CLFS.

This summary was written with AI assistance from CMS Clinical Laboratory Fee Schedule data. Amounts on this page come directly from CMS files.

How Medicare pays 0254U

Clinical lab tests aren’t priced like physician services. They’re paid from their own fee schedule, with its own rules. See the whole lab fee schedule.

One national amount

CMS sets a single Clinical Laboratory Fee Schedule amount for 0254U. There’s no geographic (GPCI) adjustment, so it pays the same in every state and payment locality.

No office or facility rate

Lab tests aren’t built from relative value units, so there’s no office and facility split: the place of service doesn’t change the CLFS amount.

Updated every quarter

CMS republishes the CLFS each quarter. New tests, often proprietary laboratory analyses (PLA codes), join during the year; existing amounts are updated each January.

Not on the physician fee schedule

The physician fee schedule doesn’t list 0254U: Medicare pays the test only from the CLFS.

0254U on the lab fee schedule since 2021

0254U · CLFS 2026 Q4 (current)

$759.05

Unchanged since Jan 1, 2023

Amount in each year’s latest CLFS release · bars start at $0

Every change on file

  1. Jan 1, 2023 · CLFS 2023 Q1MAC-priced → $759.05

22 quarterly CLFS releases on file, first CLFS 2021 Q3. A code missing from a quarter wasn’t on that release.

0254U compared with similar tests

0252UFetal DNA analysisShort tandem-repeat comparison$759.05
0252U is a fetal aneuploidy analysis using STR analysis. 0254U assesses embryonic DNA by genomic sequencing of 24 chromosomes and reports a mitochondrial DNA score for euploid embryos.
0253UReceptivity profile238-gene RNA analysis$3,159.42
0253U is a reproductive medicine RNA gene-profile assay. 0254U assesses chromosome findings in embryonic DNA by genomic sequencing.
0255USperm function testGM1 fluorescence microscopy$31.60
0255U is an andrology infertility assessment; 0254U is a genetic assessment of an embryo.

0254U billing questions

Is this test reported once per IVF cycle or per embryo?

Report one unit for each embryo tested. The assessment analyzes each embryo's DNA.

What distinguishes this test from 0253U?

0254U assesses embryonic DNA by genomic sequencing of 24 chromosomes and reports a mitochondrial DNA score for euploid embryos. 0253U describes a reproductive medicine RNA gene-profile assay.

Which findings can the report include?

Findings can include euploidy, monosomy, trisomy, partial deletions or duplications, mosaicism, and segmental aneuploidy. A mitochondrial DNA score is reported for euploid embryos.

How does Medicare pay this code?

Medicare pays 0254U through the CLFS using one national amount across localities, with no office or facility payment difference.

Where this amount comes from

FeeBase reads lab amounts directly from the CMS Clinical Laboratory Fee Schedule file for the quarter: one row per code, with its payment indicator and national amount. Contractor-priced tests are labeled, never given a made-up amount. Amounts are Medicare payment limits, not a patient’s bill or a commercial rate.

CMS CLFS 2026 Q4 · effective Oct 1, 2026 through the day before Jan 1, 2027

Show the CMS file line behind this amount
CLFS row for 0254UPUF_CLFS_CY2026_Q4V1.csv, line 224 (CLFS 2026 Q4)

Open CMS sourceHow we source rates

Did this answer your question about what Medicare pays for 0254U?

Tell us what you were actually trying to work out. We’ll answer you directly, or build the page that does.

Fee sheets · Coming soon

Put 0254U and the rest of your codes on one sheet

Your codes at your locality, with payer contracts beside Medicare.

Join the waitlist